Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
Efficient deconvolution of antibody targets is needed for phenotype-based discovery. Here, the authors investigate a deconvolution approach based on pooled CRISPR Cas9 to achieve 97% deconvolution success rate.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6e2a5135b9de48a8b79f53b16495e80f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|